Wednesday Feb 19
Generic Pharmaceuticals Deals -- Who's Next
Generic Pharmaceuticals companies have been getting a great deal of attention from Wall Street these days.
Forest Labs gets $25B buyout offer
A dominant player in generic drugs, pharmaceutical company Actavis has been looking to shift its focus to the branded business, and now, according to a report by Bloomberg , it's on the verge of acquiring New York-based Forest Laboratories for about $25 billion.
Investor's Business Daily
Generic-Drug Makers Actavis, Mylan To Report Q4 Soon
The group ranked No. 11 among the 197 industries tracked by IBD in Monday's issue, up from No.
Ferring Pharmaceuticals Inc. Receives Positive Verdict in Patent...
Ferring Pharmaceuticals Inc. today announced that their patents for LYSTEDA , a non-hormonal prescription medicine to treat heavy monthly menstrual bleeding, have been found valid and infringed by both Watson Pharmaceuticals Inc. and Apotex Inc. .
Fish & Richardson Wins Patent Infringement Suit for Allergan Over Generic LUMIGANA 0.01%
LUMIGANA 0.01 is a leading treatment for elevated eye pressure in people with glaucoma or ocular hypertension.